Apoptosis in SLE--too little or too much?
- PMID: 7531124
Apoptosis in SLE--too little or too much?
Abstract
Cells of the immune system are, most likely, programmed to die unless recruited into an immune response. An active cell death program may also be induced by a variety of soluble and surface signals, many of which have only recently been recognized. The importance of these pathways in maintaining tolerance is highlighted by the development of lupus-like diseases in three different mouse strains that have spontaneous mutations in the Fas/APO-1 receptor or its ligand. The known function of Fas/APO-1 in signalling apoptosis explains the persistence of self reactive cells in lpr mice although it is unclear, at present, whether Fas defects effect both central and peripheral tolerance. Whereas Fas/APO-1 receptor expression appears to be normal in humans with SLE, other defects in the Fas/APO-1 pathway or other key molecules in the cell death survival require further study.
Similar articles
-
Participation of the Bcl-2 and Fas molecules in experimental apoptosis of spleen B lymphocytes.Rev Invest Clin. 1997 May-Jun;49(3):171-8. Rev Invest Clin. 1997. PMID: 9294959
-
The apoptosis-1/Fas protein in human systemic lupus erythematosus.J Clin Invest. 1994 Mar;93(3):1029-34. doi: 10.1172/JCI117051. J Clin Invest. 1994. PMID: 7510716 Free PMC article.
-
Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity.Immunity. 2008 Feb;28(2):206-17. doi: 10.1016/j.immuni.2007.12.015. Immunity. 2008. PMID: 18275831
-
Bcl-2 and Fas, molecules which influence apoptosis. A possible role in systemic lupus erythematosus?Autoimmunity. 1994;17(4):271-8. doi: 10.3109/08916939409010667. Autoimmunity. 1994. PMID: 7524704 Review.
-
Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.Arthritis Rheum. 1998 Feb;41(2):344-53. doi: 10.1002/1529-0131(199802)41:2<344::AID-ART19>3.0.CO;2-J. Arthritis Rheum. 1998. PMID: 9485093 Review.
Cited by
-
CAR T cell therapy for refractory pediatric systemic lupus erythematosus: a new era of hope?Pediatr Rheumatol Online J. 2024 Aug 8;22(1):72. doi: 10.1186/s12969-024-00990-4. Pediatr Rheumatol Online J. 2024. PMID: 39118067 Free PMC article. Review.
-
Diet and Hygiene in Modulating Autoimmunity During the Pandemic Era.Front Immunol. 2022 Jan 5;12:749774. doi: 10.3389/fimmu.2021.749774. eCollection 2021. Front Immunol. 2022. PMID: 35069526 Free PMC article. Review.
-
Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells.J Immunol. 2004 Sep 15;173(6):3676-83. doi: 10.4049/jimmunol.173.6.3676. J Immunol. 2004. PMID: 15356113 Free PMC article.
-
Combination of molecular mimicry and aberrant autoantigen expression is important for development of anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.Clin Exp Immunol. 2002 Aug;129(2):359-69. doi: 10.1046/j.1365-2249.2002.01812.x. Clin Exp Immunol. 2002. PMID: 12165095 Free PMC article.
-
Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus.J Immunol. 2002 Jul 15;169(2):1092-101. doi: 10.4049/jimmunol.169.2.1092. J Immunol. 2002. PMID: 12097418 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous